Novel Medical Treatment Modalities of Endometriosis
This review explores emerging medical treatments for endometriosis, a common condition affecting reproductive-aged women with infertility and pelvic pain for which no curative therapy currently exists.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (93)
- Angiogenic Factors in Endometriosis via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Anti-angiogenic treatment of endometriosis: biochemical aspects. via openalex
- A pilot study on the off-label use of valproic acid to treat adenomyosis via openalex
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Application of the nuclear factor-κB inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study via openalex
- Atorvastatin causes regression of endometriotic implants in a rat model via openalex
- Cell Proliferation and apoptosis: Detection of apoptosis in human endometriotic tissues via openalex
- Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids via openalex
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions via openalex
- Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model via openalex
- Costunolide Induces Apoptosis in Human Endometriotic Cells through Inhibition of the Prosurvival Akt and Nuclear Factor Kappa B Signaling Pathway via openalex
- COX-2 Inhibitors and Their Role in Gynecology via openalex
- Curcumin as anti-endometriotic agent: Implication of MMP-3 and intrinsic apoptotic pathway via openalex
- Economic burden of endometriosis via openalex
- Effect of a Statin on an In Vitro Model of Endometriosis via openalex
- Effect of the immunomodulator leflunomide on the induction of endometriosis in an experimental rat model via openalex
- Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis via openalex
- Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia via openalex
- Effects of pinealectomy and melatonin supplementation on endometrial explants in a rat model via openalex
- Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons via openalex
- Efficacy of imiquimod, an immunomodulatory agent, on experimental endometriosis via openalex
- Efficacy of levamisole on experimental endometriosis via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator via openalex
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility via openalex
- Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo via openalex
- Evidence for Oxidatively Modified Lipid-Protein Complexes in Endometrium and Endometriosis via openalex
- Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours via openalex
- Extracellular Matrix-Dependent Regulation of Fas Ligand Expression in Human Endometrial Stromal Cells via openalex
- Fenofibrate causes regression of endometriotic implants: a rat model via openalex
- FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model via openalex
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? via openalex
- Interleukin-12 inhibits development of ectopic endometriotic tissues in peritoneal cavity via activation of NK cells in a murine endometriosis model via openalex
- In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells via openalex
- Matrix Metalloproteinases and Endometriosis via openalex
- Medical Therapy for Endometriosis via openalex
- Medical treatments for endometriosis. via openalex
- Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile via openalex
- Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex
- More than antioxidant: N-acetyl-L-cysteine in a murine model of endometriosis via openalex
- Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells via openalex
- Oxidative stress may be a piece in the endometriosis puzzle via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress via openalex
- Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial via openalex
- Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation via openalex
- Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. via openalex
- Regression of endometrial autografts in a rat model of endometriosis treated with etanercept via openalex
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin via openalex
- Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis via openalex
- Role of melatonin in regulating matrix metalloproteinase‐9 via tissue inhibitors of metalloproteinase‐1 during protection against endometriosis via openalex
- SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model via openalex
- Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis via openalex
- Statins Inhibit Growth of Human Endometrial Stromal Cells Independently of Cholesterol Availability1 via openalex
- Suppression of the Development of Experimentally Induced Uterine Adenomyosis by a Novel Matrix Metalloproteinase Inhibitor, ONO-4817, in Mice via openalex
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis via openalex
- Thiazolidinediones as Therapy for Endometriosis: A Case Series via openalex
- Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon via openalex
- Valproic Acid and Progestin Inhibit Lesion Growth and Reduce Hyperalgesia in Experimentally Induced Endometriosis in Rats via openalex
- Vitamin E and C supplementation reduces endometriosis related pelvic pain via openalex
- W2182665322 via openalex
- W1970960196 via openalex
- W1910306760 via openalex
- W4376453583 via openalex
- W6641328778 via openalex
- W6644175530 via openalex
- W6645769035 via openalex
- W6658719099 via openalex
- W6660039260 via openalex
- W6665939090 via openalex
- W6675273733 via openalex
- W6850047429 via openalex
- W2160829078 via openalex
- W2082368668 via openalex
- W2070036336 via openalex
- W2066030592 via openalex
- W2053935373 via openalex
- W2046640023 via openalex
- W2045793734 via openalex
- W2126267641 via openalex
- W2032738969 via openalex
- W2132536626 via openalex
- W2132621306 via openalex
- W2001163191 via openalex
- W2137773942 via openalex
- W2140246703 via openalex
- W1992125460 via openalex
- W1975745957 via openalex
- W2144939915 via openalex
- W2078741915 via openalex
- W2164960015 via openalex
Cited by (3)
- Difficulties in Differentiation of Malignant Neoplasms and Deep Infiltrative Endometriosis 2022
- A combined approach to treating patients with severe forms of endometriosis-associated infertility 2017
- Combined treatment of endometriosis in infertile patients with gonadotropin-releasing hormone agonist or dienogest 2016
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00